SCYNEXIS Inc (SCYX)
1.77
-0.01
(-0.56%)
USD |
NASDAQ |
May 03, 16:00
1.78
+0.01
(+0.56%)
Pre-Market: 20:00
SCYNEXIS Price to Book Value: 0.9159 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 0.9159 |
May 02, 2024 | 0.921 |
May 01, 2024 | 0.89 |
April 30, 2024 | 0.8745 |
April 29, 2024 | 0.9417 |
April 26, 2024 | 0.7969 |
April 25, 2024 | 0.7606 |
April 24, 2024 | 0.7762 |
April 23, 2024 | 0.802 |
April 22, 2024 | 0.7451 |
April 19, 2024 | 0.7451 |
April 18, 2024 | 0.727 |
April 17, 2024 | 0.7348 |
April 16, 2024 | 0.7296 |
April 15, 2024 | 0.7606 |
April 12, 2024 | 0.7477 |
April 11, 2024 | 0.8279 |
April 10, 2024 | 0.8176 |
April 09, 2024 | 0.8434 |
April 08, 2024 | 0.8434 |
April 05, 2024 | 0.8848 |
April 04, 2024 | 0.8693 |
April 03, 2024 | 0.9314 |
April 02, 2024 | 0.7503 |
April 01, 2024 | 0.771 |
Date | Value |
---|---|
March 28, 2024 | 0.7606 |
March 27, 2024 | 0.7374 |
March 26, 2024 | 0.7192 |
March 25, 2024 | 0.7399 |
March 22, 2024 | 0.7192 |
March 21, 2024 | 0.7244 |
March 20, 2024 | 0.7296 |
March 19, 2024 | 0.7451 |
March 18, 2024 | 0.7451 |
March 15, 2024 | 0.7503 |
March 14, 2024 | 0.7762 |
March 13, 2024 | 0.7917 |
March 12, 2024 | 0.8279 |
March 11, 2024 | 0.8331 |
March 08, 2024 | 0.859 |
March 07, 2024 | 0.8745 |
March 06, 2024 | 0.8641 |
March 05, 2024 | 0.8538 |
March 04, 2024 | 0.8434 |
March 01, 2024 | 0.8383 |
February 29, 2024 | 0.8261 |
February 28, 2024 | 0.8669 |
February 27, 2024 | 0.8669 |
February 26, 2024 | 0.8771 |
February 23, 2024 | 0.8567 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.631
Minimum
Nov 29 2023
30.30
Maximum
Mar 30 2023
5.833
Average
5.209
Median
Jun 11 2019
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 2.094 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7539 |
Theriva Biologics Inc | 0.187 |
Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
PE Ratio | 1.362 |
PS Ratio | 0.611 |
Price to Free Cash Flow | 1.423 |
Price | 1.77 |
Earnings Yield | 73.45% |
Market Cap | 66.82M |
Operating PE Ratio | 1.178 |
Normalized PE Ratio | 1.273 |